Search

Your search keyword '"Gross-Paju, Katrin"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Gross-Paju, Katrin" Remove constraint Author: "Gross-Paju, Katrin"
109 results on '"Gross-Paju, Katrin"'

Search Results

1. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

2. Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment

3. Stroke in COVID-19

4. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

5. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

7. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

11. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

13. The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia

14. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

17. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

18. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

19. sj-docx-1-msj-10.1177_13524585211044479 – Supplemental material for Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

20. Global Impact of COVID-19 on Stroke Care and Intravenous Thrombolysis

21. Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis

22. Bladder dysfunction in hereditary spastic paraplegia: what to expect?

23. Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis (1462)

24. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.

25. Posterioorne kortikaalne atroofia – nägemishäirena avalduva varajase algusega Alzheimeri tõve haigusjuhu kirjeldus

26. Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements

27. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

28. Intravenous versus subcutaneous immunoglobulin – Authors' reply

29. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

33. Intravenous versus subcutaneous immunoglobulin – Authors' reply

34. Neuroloogia

36. Insuldi käsitlus Eestis: hetkeseis ja suundumused

37. Hereditaarset spastilist parapleegiat süsteemselt käsitlenud uuring Eestis tõi esile uusi andmeid

38. Sclerosis multiplex’i tänapäevane ravi

39. Dopamiinitundlik düstoonia: kirjanduse ülevaade ja haigusjuhu kirjeldus

40. Kognitiiv-käitumisteraapia kroonilise valu ravis

43. Sclerosis multiplex ja rasedus

49. Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements

Catalog

Books, media, physical & digital resources